Radio Frequency Identification (RFID) in Pharmaceuticals - Supply Chain Security Concerns Provide Impetus for RFID Adoption
Summary
GBI Research, the leading business intelligence provider, has released its latest research, “Radio Frequency Identification (RFID) in Pharmaceuticals - Supply Chain Security Concerns Provides Impetus for RFID Adoption.” It provides key data and analysis of the major factors affecting the market for RFID in the pharmaceuticals industry. This pharmaceutical and healthcare report also analyzes the strengths, weaknesses, opportunities and threats in the RFID market within the pharmaceutical industry and the key market drivers and barriers to the adoption of RFID in the industry.
The report is based on proprietary databases, primary and secondary research, and in-house analysis by GBI Research’s team of industry experts.
The global market for Radio Frequency Identification (RFID) products and services in the pharmaceutical industry was valued at $112m in 2008 and is expected to grow to $884m in 2015 at a CAGR of 34% over the same period. The market for RFID hardware is the largest at the initial stages of adoption in the pharmaceutical industry. Service providers are gaining market share by integrating their services with one-stop solutions. The share of hardware in the RFID market is estimated to be 60% in 2008 and includes tags, readers and label printers. The share of software and services in the RFID market is estimated to be 40% in 2008. RFID services include installation, integration, training, maintenance and IT support.
GBI Research’s analysis suggests that the RFID technology is in the early stages of adoption within the pharmaceutical industry. The market for RFID in pharmaceuticals is hampered by low adoption rates due to apprehensions over high investments and the lack of a clear business case. However, solutions for the pharmaceutical industry are evolving to address the concerns responsible for the slow growth. RFID vendors are offering pilot kits for the pharmaceutical industry to test and evaluate RFID technology so that clients can understand the technology’s costs and benefits. RFID adoption rate will be low initially due to budget restrictions in the pharmaceutical industry as a result of the global recession and subsequent cost cutting measures. However, the adoption rate is expected to increase rapidly due to mandates from retailers like Wal-Mart and from regulatory authorities like the California Board of Pharmacy for the implementation of e-Pedigree in the supply chain. In essence, RFID is the most promising solution for the elimination of counterfeits in the pharmaceutical supply chain. However, realization of the technology’s potential benefits is possible only if apprehensions about the initial costs of implementation, return-on-investment and a weak business case are addressed.
Scope
The scope of this report includes:
- Analysis of the opportunities and challenges for Radio Frequency Identification technology providers in the pharmaceuticals industry
- Market revenues and forecasts for RFID solutions in the global pharmaceutical industry from 2008 to 2015
- The market for RFID hardware, software and services in the pharmaceutical industry including track-and-trace solutions and e-Pedigree solutions
- Qualitative analysis of the market drivers, barriers, future outlook and challenges for RFID adoption in the pharmaceutical industry
- Coverage of key geographies including the US, Germany, the UK, France, Spain, Italy and Japan
- Analysis of technology adoption framework for RFID hardware, software and services in the pharmaceutical industry
- Information and analysis on the competitive landscape and the leading market players such as Alien Technologies, SupplyScape, Zebra Technologies Corporation, TAGSYS Inc and IBM
Reasons to buy
The report will enhance your decision making and will enable you to:
- Formulate strategies to increase your company’s growth by understanding the new growth opportunities for RFID technologies within the pharmaceutical market
- Draft efficient strategies by understanding best practices, identifying key winners and losers and who is best positioned to take advantage of the emerging market opportunities
- Overcome regulatory and technology hurdles by identifying the key trends shaping and driving the RFID markets in pharmaceutical industry
- Make more informed business decisions from the insightful and in-depth analysis of the market for RFID in pharmaceuticals and the factors shaping its adoption
- Differentiate yourself from competitors and develop new solutions for the pharmaceutical industry by understanding the current competitive landscape and how it is evolving to meet the needs of the pharmaceutical industry
Global Network Equipment Industry
1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 7
1.2 List of Figures8
2 Introduction 9
2.1 GBI Research Report Guidance 9
3 Radio Frequency Identification (RFID) in Pharmaceuticals – Overview of the Pharmaceutical Supply Chain 11
3.1 Overview of the Pharmaceutical Supply Chain 11
3.2 Pharmaceutical Supply Chain Models 12
3.2.1 Traditional Wholesaler Model 12
3.2.2 Limited Distribution Model 13
3.2.3 Direct Distribution Model 14
4 Radio Frequency Identification (RFID) in Pharmaceuticals – Overview of RFID Technology 17
4.1 RFID Applications in the Supply Chain 17
4.2 RFID Tags 17
4.2.1 Introduction 17
4.3 RFID Readers 20
4.4 RFID Infrastructure 20
5 Radio Frequency Identification (RFID) in Pharmaceuticals – Unmet Needs in the Pharmaceutical Industry 22
5.1 Counterfeit Problems Due to Unauthorized Secondary Wholesalers 22
5.2 Counterfeit Issues in Parallel Trade 22
5.3 Counterfeit Problems Due to Product Shortages 24
5.4 Counterfeit Problems Due to Repackaging 25
5.5 Counterfeit Introduction in Drug Re-Importation 26
5.6 Markets for Counterfeit Drugs 27
5.6.1 Costs to the Pharmaceutical Industry due to Counterfeiting 32
5.6.2 High Costs Due to Drug Callbacks 34
5.6.3 Operational Inefficiency and Costs in Inventory Management 36
5.6.4 Inaccurate Transactions in Chargeback Management 36
5.6.5 Increasing Cost and High Percentage of Errors in Clinical Trials 36
6 Radio Frequency Identification (RFID) in Pharmaceuticals – RFID as a Solution for the Pharmaceutical Industry 37
6.1 Solutions for the Pharmaceutical Industry 37
6.1.1 E-Pedigree Solutions 37
6.1.2 Track and Trace Solutions 39
6.1.3 Product Callback Management 40
6.1.4 Authentication of Drugs in the Supply Chain 40
6.1.5 Inventory Management 40
6.1.6 Sample Distribution Management 40
6.1.7 Clinical Trial Solutions 41
6.2 Costs of RFID Solutions 41
6.3 Considerations for RFID Implementation 42
6.3.1 Parent-Child Relationship for Choice between HF and UHF Frequencies 43
6.3.2 Pilot Phase Execution 43
6.4 Pharmaceutical Industry’s Priorities for RFID Implementation 44
6.4.1 Retailer Mandates for RFID implementation Pushes Pharmaceutical Manufacturers to Adopt RFID Technology 45
6.5 Considerations for Total Enterprise Management 45
6.6 Business Process Reengineering for RFID Implementation 46
6.6.1 Reengineering Packaging Processes 46
6.6.2 Reengineering Tag Placements 46
6.6.3 Slap-and-Ship Applications May Suit Smaller Enterprises 47
6.6.4 Reengineering Site Processes 47
6.7 RFID Implementation and Maximization of Benefit 47
7 Radio Frequency Identification (RFID) in the Pharmaceuticals – Market Characterization 50
7.1 Market Forecasts for RFID in Pharmaceuticals 50
7.2 Technology Adoption Framework for RFID Solutions 52
7.3 Drivers for the Adoption of RFID Solutions 54
7.3.1 Increasing Counterfeit Incidents Accentuate the Urgent Need for RFID Implementation 54
7.3.2 Mandates by Drug Retailers and Pharmacies Increases Adoption of RFID systems by Pharmaceutical Manufacturers 54
7.3.3 Harmonization of UHF Standards and the Elimination of Listen before Talk Protocol in Europe is Likely to Spur Growth 55
7.3.4 Pedigree Requirements in the Pharmaceutical Industry will Accelerate RFID Implementation 55
7.4 Barriers for the Adoption of RFID Solutions 55
7.4.1 High Cost of Implementation Raises Concerns over Return on Investment 56
7.4.2 Management of Overload in Data Due to Large Scale RFID Implementation is a Challenge 56
7.4.3 High Costs and Time Consumption of Mass Serialization Deters Adoption 56
7.5 SWOT Analysis 57
8 Radio Frequency Identification (RFID) in the Pharmaceuticals – Competitive Landscape 58
8.1 Value Chain in the RFID Industry 58
8.1.1 Automated Packaging and Tagging Solution Providers 58
8.1.2 Software Solutions Providers 59
8.1.3 Providers of Pilot Kits 59
8.1.4 One-Stop Solution Providers 59
8.2 Pharmaceutical Industry’s Priorities Shape the Growth of RFID Markets 61
8.3 RFID Systems Compete with Cheaper Barcode Systems 62
9 Radio Frequency Identification (RFID) in the Pharmaceuticals – Regulatory Landscape 64
9.1 Regulations in the US Encourage RFID Adoption in the Pharmaceutical Industry 64
9.1.1 The Prescription Drug Marketing Act of 1987 (PDMA) 64
9.1.2 California Pedigree Legislation’s Deadline has been Postponed on Multiple Occasions Due to the Challenges Faced in RFID Implementation 64
9.2 Regulations in Europe are not yet Favorable for Rapid RFID Adoption 65
9.2.1 Code Structures for Unique Identification Differ across European Countries 65
9.2.2 Harmonization of Regulations for UHF in Europe is Expected to Increase Adoption 65
10 Radio Frequency Identification (RFID) in Pharmaceuticals - Case Studies 67
10.1 Case Study: RFID implementation in Direct-to-Pharmacy Distribution Channel 67
10.2 Pfizer 68
10.2.1 Challenge 68
10.2.2 Solution 68
10.3 GlaxoSmithKline 68
10.3.1 Challenge 68
10.3.2 Solution 68
10.4 Purdue Pharma 69
10.4.1 Challenge 69
10.4.2 Solution 69
11 Radio Frequency Identification (RFID) in the Pharmaceutical Industry – Company Profiles 70
11.1 Alien Technology 70
11.2 Avery Dennison 71
11.3 Blue Vector 72
11.4 Hewlett-Packard 73
11.5 International Business Machines (IBM) Corporation 74
11.6 Intermec, Inc. 75
11.7 Motorola, Inc 76
11.8 Siemens 77
11.9 SupplyScape 78
11.10 SureID 79
11.11 TAGSYS Inc 80
11.12 Texas Instruments 81
11.13 Toshiba Tec 82
11.14 UPM Raflatac 82
11.15 VeriSign 83
11.16 Zebra Technologies Corporation 84
12 Appendix 86
12.1 Market Definitions 86
12.2 Abbreviations 86
12.3 Research Methodology 87
12.3.1 Coverage 88
12.3.2 Secondary Research 88
12.3.3 Primary Research 89
12.3.4 Expert Panel Validation 89
12.4 Contact Us 89
12.5 Disclaimer 89
1.1 List of Tables
Table 1: RFID in Pharmaceuticals, Share of Parallel Imports in Pharmacy Sales (%), 2007 24
Table 2: RFID in Pharmaceuticals, Number of Counterfeiting Cases Opened by the US FDA, 1997-2006 28
Table 3: RFID in Pharmaceuticals, Number of Counterfeit Cases Reported in Europe,
2006-2008 29
Table 4: RFID in Pharmaceuticals, Number of Counterfeit Medicines Seized in Europe,
2006-2008 30
Table 5: RFID in Pharmaceuticals, Share of Counterfeit Drugs Seized in Europe by Country of Origin, 2006-2008 31
Table 6: RFID in Pharmaceuticals, Number of Drug Callbacks in the US, 1997-2007 34
Table 7: RFID in Pharmaceuticals, Global, Revenues ($m), 2008-2015 50
Table 8: RFID in Pharmaceuticals, Alien Technology, 2010 70
Table 9: RFID in Pharmaceuticals, Avery Dennison, 2010 71
Table 10: RFID in Pharmaceuticals, Blue Vector, 2010 72
Table 11: RFID in Pharmaceuticals, Hewlett-Packard, 2010 73
Table 12: RFID in Pharmaceuticals, International Business Machines (IBM) Corporation, 2010 74
Table 13: RFID in Pharmaceuticals, Intermec, Inc, 2010 75
Table 14: RFID in Pharmaceuticals, Motorola, Inc, 2010 76
Table 15: RFID in Pharmaceuticals, Siemens, 2010 77
Table 16: RFID in Pharmaceuticals, SupplyScape, 2010 78
Table 17: RFID in Pharmaceuticals, SureID, 2010 79
Table 18: RFID in Pharmaceuticals, TAGSYS, Inc, 2010 80
Table 19: RFID in Pharmaceuticals, Texas Instruments, 2010 81
Table 20: RFID in Pharmaceuticals, Toshiba TEC, 2010 82
Table 21: RFID in Pharmaceuticals, UPM Raflatac, 2010 82
Table 22: RFID in Pharmaceuticals, VeriSign, 2010 83
Table 23: RFID in Pharmaceuticals, Zebra Technologies Corporation, 2010 84
1.2 List of Figures
Figure 1: RFID in Pharmaceuticals, Structure of a Traditional Distribution Channel 13
Figure 2: RFID in Pharmaceuticals, Structure of a Limited Distribution Channel 14
Figure 3: RFID in Pharmaceuticals, Structure of a Direct-to-Pharmacy Distribution Channel 16
Figure 4: RFID in Pharmaceuticals, Components of an RFID System 17
Figure 5: RFID in Pharmaceuticals, Classification of RFID Tags 18
Figure 6: RFID in Pharmaceuticals, Comparison of Passive and Active Tags 18
Figure 7: RFID in Pharmaceuticals, Comparison of Radio Wave Frequencies 19
Figure 8: RFID in Pharmaceuticals, Communication in an RFID Infrastructure 21
Figure 9: RFID in Pharmaceuticals, Counterfeit Intrusion in Parallel Trade 23
Figure 10: RFID in Pharmaceuticals, Share of Parallel Imports in Pharmacy Sales (%), 2007 23
Figure 11: RFID in Pharmaceuticals, Counterfeit Intrusion Due to Product Shortage 25
Figure 12: RFID in Pharmaceuticals, Counterfeit Intrusion Due to Repackaging 26
Figure 13: RFID in Pharmaceuticals, Number of Counterfeiting Cases Opened by the US FDA, 1997-2006 27
Figure 14: RFID in Pharmaceuticals, Number of Counterfeit Cases Reported in Europe, 2006-2008 29
Figure 15: RFID in Pharmaceuticals, Number of Counterfeit Medicines Seized in Europe, 2005-2008 30
Figure 16: RFID in Pharmaceuticals, Share of Counterfeit Drugs Seized in Europe by Country of Origin, 2006-2008 31
Figure 17: RFID in Pharmaceuticals, Share of Counterfeits in Pharmaceutical Markets, 2008 32
Figure 18: RFID in Pharmaceuticals, Impact of Counterfeit Zyprexa on Eli Lilly’s Share Prices, Oct 2001 – Jul 2004 33
Figure 19: RFID in Pharmaceuticals, Impact of Combivir Counterfeiting on GlaxoSmithKline’s Share Prices, May 2001- May 2004 33
Figure 20: RFID in Pharmaceuticals, Number of Drug Callbacks in the US, 1997-2007 34
Figure 21: RFID in Pharmaceuticals, Impact of Vioxx Withdrawal on Merck’s Share Prices, Apr 2003- Oct 2006 35
Figure 22: RFID in Pharmaceuticals, e-Pedigree in a Pharmaceutical Supply Chain 37
Figure 23: RFID in Pharmaceuticals, Paper Based Pedigree in a Pharmaceutical Supply Chain 38
Figure 24: RFID in Pharmaceuticals, Information Flow in Track-and-Trace Applications 39
Figure 25: RFID in Pharmaceuticals, Costs of Implementation in Distribution Channels, 2008 41
Figure 26: RFID in Pharmaceuticals, Considerations for RFID Implementation, 2010 42
Figure 27: RFID in Pharmaceuticals, Attractiveness Matrix for RFID, 2008 44
Figure 28: RFID in Pharmaceuticals, Considerations for Total Enterprise Management, 2010 46
Figure 29: RFID in Pharmaceuticals, Maximization of Benefits Through RFID Implementation, 2010 47
Figure 30: RFID in Pharmaceuticals, Benefits Due to RFID in the Pharmaceutical Supply Chain, 2010 48
Figure 31: RFID in Pharmaceuticals, Supply Chain Maturity Due to RFID Adoption, 2010 49
Figure 32: RFID in Pharmaceuticals, Global, Revenue Forecasts ($m), 2008- 2015 50
Figure 33: RFID in Pharmaceuticals, Demand for Hardware and Services in the Early Stage of Adoption, 2008 51
Figure 34: RFID in Pharmaceuticals, Technology Adoption Framework for RFID Technology, 2008 52
Figure 35: RFID in Pharmaceuticals, Drivers and Barriers for the RFID Market, 2008-2015 54
Figure 36: RFID in Pharmaceuticals, Impact Analysis for RFID Adoption, 2008 55
Figure 37: RFID in Pharmaceuticals, SWOT Analysis, 2008 57
Figure 38: RFID in Pharmaceuticals, Value Chain in the RFID Industry, 2010 58
Figure 39: RFID in Pharmaceuticals, RFID Solutions Mapping to Implementation Challenges, 2010 60
Figure 40: RFID in Pharmaceuticals, Example of One-Stop Solution - California Express Solution, 2010 61
Figure 41: RFID in Pharmaceuticals, Priority of Solutions for Implementation in the Pharmaceutical Industry, 2008 62
Figure 42: RFID in Pharmaceuticals, Comparison of RFID and 2D Barcode Systems, 2010 63
Figure 43: RFID in Pharmaceuticals, Information Requirements on Pedigree, 2008 65
Figure 44: RFID in Pharmaceuticals, Advantage of e-Pedigree in a Direct-to-Pharmacy Distribution, 2010 67
Figure 45: GBI Research Methodology 88
Companies Mentioned
Pfizer
GlaxoSmithKline
Purdue Pharma
